BanuK.ArunMD

PubMed

• Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data.
  Nam H Nguyen, Elissa B Dodd-Eaton, Jessica L Corredor, Sierra Green, Angelica M Gutierrez, Wenyi Wang, Jacynda Woodman-Ross, Banu K Arun> ;Journal of Clinical Oncology. 2024 Apr 3
• Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
  Daniel R Barnes, Jonathan P Tyrer, Joe Dennis, Goska Leslie, Manjeet K Bolla, Michael Lush, Amber M Aeilts, Kristiina Aittomäki, Nadine Andrieu, Irene L Andrulis, Hoda...> ;Medrxiv. 2024 Mar 4
• Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes.
  Reva K Basho, Li Zhao, Jason B White, Lei Huo, Roland L Bassett, Elizabeth A Mittendorf, Alastair Thompson, Jennifer K Litton, Naoto Ueno, Banu Arun, Bora Lim, Vicente...> ;JCO Precision Oncology. 2024 Mar 1
• Hematologic malignancies in Li-Fraumeni syndrome: A case report.
  Bethany Bundrant, Yoheved Gerstein, Banu Arun, Courtney D DiNardo> ;American Journal of Medical Genetics. Part A. 2024 Feb 27
• Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers.
  Brant Gracia, Patricia Montes, Angelica Maria Gutierrez, Banu Arun, Georgios Ioannis Karras> ;Cell Reports. 2024 Feb 27
• Limited Independent Follow-Up with Germline Testing of Variants Detected inandby Tumor-Only Sequencing.
  Nowlen, C., Daniels, M., Uzunparmak, B., Ileana Dumbrava, E., Yuan, Y., Patel, K., Rayes, N., Harkenrider, J., Wathoo, C., Veazie, J., Luna, K., Wang, W., Horombe, C.,...> ;Journal of Immunotherapy and Precision Oncology. 2024 Feb 1
• LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious GermlineMutations.
  Nguyen, N., Dodd-Eaton, E., Peng, G., Corredor, J., Jiao, W., Wang, W., Woodman-Ross, J., Arun, B.> ;JCO Clinical Cancer Informatics. 2024 Feb 1
• Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): Final overall survival results from a randomized phase 3 trial.
  Diéras, V., Wildiers, H., Friedlander, M., Ayoub, J., Puhalla, S., Loirat, D., Ratajczak, C., Adamu, H., Girardi, V., Han, H., Arun, B.> ;European Journal of Cancer. 2024 Mar 1
• Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline.
  Al Sukhun, S., Temin, S., Barrios, C., Antone, N., Guerra, Y., Chavez-MacGregor, M., Chopra, R., Danso, M., Gomez, H., Homian, N., Kandil, A., Kithaka, B., Koczwara, B...> ;JCO Global Oncology. 2024 Jan 1
• Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline Q and A.
  Al Sukhun, S., Koczwara, B., Temin, S., Arun, B.> ;JCO Global Oncology. 2024 Jan 1
• Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutations.
  Fatma Nihan Akkoc Mustafayev, Mihir Amitabh Shukla, Amanda Lanier, Denái R Milton, Angelica M Gutierrez, Stephen K Gruschkus, John E Lewis, Rashmi K Murthy, Banu K Arun> ;Cancer. 2024 May 1
• 11 citations
  NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
  Mary B Daly, Tuya Pal, Kara N Maxwell, Jane Churpek, Wendy Kohlmann, Zahraa AlHilli, Banu Arun, Saundra S Buys, Heather Cheng, Susan M Domchek, Susan Friedman, Veda Gi...> ;Journal of the National Comprehensive Cancer Network. 2023 Oct 1
• Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.
  Fatma Nihan Akkoc Mustafayev, Diane D Liu, Angelica M Gutierrez, John E Lewis, Nuhad K Ibrahim, Vicente Valero, Daniel J Booser, Jennifer K Litton, Kimberly Koenig, Di...> ;European Journal of Breast Health. 2023 Oct 1
• Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers.
  Hui Chen, Jenna Koenig, Yun Wu, Isabelle Bedrosian, Banu Arun, Qingqing Ding, Laila Khazai, Erika Resetkova, Lei Huo, Nour Sneige, Constance Albarracin, Wang, J.> ;Breast Cancer Research and Treatment. 2024 Jan 1
• Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a sin...
  Nam H Nguyen, Elissa B Dodd-Eaton, Jessica L Corredor, Jacynda Woodman-Ross, Sierra Green, Nathaniel D Hernandez, Angelica M Gutierrez Barrera, Banu K Arun, Wenyi Wang> ;Medrxiv. 2023 Sep 2
• LFSPROShiny: an interactive R/Shiny app for prediction and visualization of cancer risks in families with deleterious germlinemutations.
  Nam H Nguyen, Elissa B Dodd-Eaton, Gang Peng, Jessica L Corredor, Wenwei Jiao, Jacynda Woodman-Ross, Banu K Arun, Wenyi Wang> ;Medrxiv. 2023 Aug 15
• 2 citations
  ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.
  Lenka Stolarova, Petra Kleiblova, Petra Zemankova, Barbora Stastna, Marketa Janatova, Jana Soukupova, Maria Isabel Achatz, Christine Ambrosone, Paraskevi Apostolou, Ba...> ;Clinical Cancer Research. 2023 Aug 15
• 1 citations
  Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospecti...
  Nour Abuhadra, Ryan Sun, Clinton Yam, Gaiane M Rauch, Qingqing Ding, Bora Lim, Alastair M Thompson, Elizabeth A Mittendorf, Beatriz E Adrada, Senthil Damodaran, Kiran ...> ;Cancers. 2023 Jun 21
• 4 citations
  17β-estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer.
  Rares Drula, Barbara Pardini, Xiao Fu, Mireia Cruz De Los Santos, Ancuta Jurj, Lan Pang, Sherien M El-Daly, Linda Fabris, Erik Knutsen, Mihnea P Dragomir, Recep Bayrak...> ;Proceedings of the National Academy of Sciences of the United States of America. 2023 Jun 6
• Practices and Views of US Oncologists and Genetic Counselors Regarding Patient Recontact After Variant Reclassification: Results of a Nationwide Survey.
  Sukh Makhnoon, Elenita Davidson, Brian Shirts, Banu Arun, Sanjay Shete> ;JCO Precision Oncology. 2023 Jun 1
• 3 citations
  PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.
  Taru A Muranen, Anna Morra, Sofia Khan, Daniel R Barnes, Manjeet K Bolla, Joe Dennis, Renske Keeman, Goska Leslie, Michael T Parsons, Qin Wang, Thomas U Ahearn, Kristi...> ;NPJ Breast Cancer. 2023 May 12
• Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.
  Nour Abuhadra, Ryan Sun, Roland L Bassett Jr, Lei Huo, Jeffrey T Chang, Mediget Teshome, Alyson R Clayborn, Jason B White, Elizabeth E Ravenberg, Beatriz E Adrada, Ros...> ;Investigational New Drugs. 2023 Jun 1
• 1 citations
  Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems.
  Erica M Bednar, Minxing Chen, Michael T Walsh Jr, Amanda L Eppolito, Molly H Klein, Kelly Teed, Brittany Hodge, Jordan Hunter, Han Gill Chao, Dillon Davis, Wilshauna S...> ;Gynecologic Oncology. 2023 May 1
• ASO Author Reflections: Other Cancers in Patients with Breast Cancer Who Undergo Germline Testing.
  Brittany L Murphy, Banu K Arun> ;Annals of Surgical Oncology. 2023 May 1
• PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens.
  Hui Chen, Qingqing Ding, Laila Khazai, Li Zhao, Senthil Damodaran, Jennifer K Litton, Gaiane M Rauch, Clinton Yam, Jeffrey T Chang, Sahil Seth, Bora Lim, Alastair M Th...> ;Therapeutic Advances in Medical Oncology. 2023 Jan 1
• Join now to see all

Journal Articles

• Functional Mechanisms Underlying Pleiotropic Risk Alleles at the 19p13.1 Breast–Ovarian Cancer Susceptibility Locus  
  Susan M Domchek, Beth Y Karlan, Katherine L Nathanson, Kenneth Offit, Banu K Arun, Andrew Berchuck, Patricia A Ganz, Douglas A Levine, Nature

Lectures

• Evaluation for Genetic Risk of Breast Cancer in Mammography Centers 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
• Non-BRCA hereditary gene mutations and breast cancer phenotype: An ISC-RAM Consortia study. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018